EHRA Premium Access

Screening for atrial fibrillation - a pro/con debate

Event: EHRA 2022
Topic: Clinical
Session type: Debate Session
Date: 4 April 2022
Time: 08:30 - 09:30

Congress Session

Become an EHRA member to access this resource

Become a member

Already a member? Sign in

6 presentations in this session

Go! Screening is here to stay - pro.

Speaker: Professor R. Schnabel (Hamburg, DE)

Stop! No need to screen - con.

Speaker: Professor J. Svendsen (Copenhagen, DK)

To screen or not to screen for atrial fibrillation – discussion.


Stroke is associated with atrial fibrillation.

Speaker: Doctor J. Healey (Hamilton, CA)

Stroke is associated with comorbidities.

Speaker: Professor S. Freedman (Sydney, AU)

Stroke is associated with atrial fibrillation or with comorbidities - discussion.


4 speakers from this session

Professor Renate B Schnabel

University Heart and Vascular Center Hamburg, Hamburg (Germany)
22 presentations

Professor Jesper Hastrup Svendsen

Copenhagen University Hospital - Rigshospitalet, Copenhagen (Denmark)
5 presentations
1 follower

Doctor Jeff Healey

Population Health Research Institute, Hamilton (Canada)
12 presentations
0 follower

Professor S Benedict Freedman

Heart Research Institute, Sydney (Australia)
7 presentations
0 follower

This platform is supported by

logo Novo Nordisk